Stockscreener 앱 받기
1.625
2.71%
-0.035
전일 마감가:
$1.66
열려 있는:
$1.66
하루 거래량:
476.67K
Relative Volume:
0.40
시가총액:
$164.48M
수익:
$97.06M
순이익/손실:
$-130.39M
주가수익비율:
-1.0484
EPS:
-1.55
순현금흐름:
$-186.54M
1주 성능:
-13.64%
1개월 성능:
-5.00%
6개월 성능:
-69.00%
1년 성능:
-76.90%
1일 변동 폭
$1.5509
$1.685
1주일 범위
$1.5509
$2.09
52주 변동 폭
$1.55
$7.57
알렉터 Stock (ALEC) Company Profile
명칭
Alector Inc
전화
415-231-5660
주소
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
ALEC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.625 | 164.48M | 97.06M | -130.39M | -186.54M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
697.91 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
618.58 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.92 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
268.98 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
알렉터 Stock (ALEC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2024-12-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-11-29 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-26 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-09-25 | 개시 | Goldman | Sell |
| 2023-09-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-09-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-13 | 개시 | Goldman | Sell |
| 2022-03-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-27 | 개시 | William Blair | Outperform |
| 2021-01-15 | 재개 | BofA Securities | Buy |
| 2020-06-24 | 개시 | H.C. Wainwright | Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-06 | 개시 | Citigroup | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-02-19 | 개시 | Stifel | Buy |
| 2019-11-21 | 개시 | BTIG Research | Buy |
| 2019-03-04 | 개시 | Barclays | Overweight |
| 2019-03-04 | 개시 | BofA/Merrill | Buy |
| 2019-03-04 | 개시 | Morgan Stanley | Overweight |
| 2019-03-04 | 개시 | SVB Leerink | Outperform |
모두보기
알렉터 주식(ALEC)의 최신 뉴스
Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Alector’s Earnings Call: Progress Amid Challenges - TipRanks
Alector Inc (ALEC) Shares Up Despite Recent Market Volatility - The News Heater
Alector, Inc. (NASDAQ:ALEC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction By Investing.com - Investing.com South Africa
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising Clinical Advances - GuruFocus.com
Alector: Q4 Earnings Snapshot - mySA
The Bold Bet on Brain Health: Alector’s Race Against Time in Neurodegenerative Research - Smartphone Magazine
Alector Inc (NASDAQ:ALEC): The Biotech Pioneering New Frontiers in Neurodegenerative Diseases - Jomfruland.net
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ... - Yahoo Finance
Alector, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Alector’s 2024 Financial Results and Clinical Advancements - TipRanks
Alector (ALEC) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction - Investing.com
Alector beats Q4 estimates, shares edge higher By Investing.com - Investing.com Canada
Alector beats Q4 estimates, shares edge higher - Investing.com India
Alector, Inc. SEC 10-K Report - TradingView
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire
Can Alector's $413M Cash Position Fuel Its Alzheimer's Breakthrough? Q4 Results Reveal Strategy - StockTitan
Alector Inc (ALEC) Q4 2024 Earnings Report Preview: What to Expect - Yahoo Finance
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Can Alector's March Conference Circuit Signal Progress in Neurodegeneration Therapies? - StockTitan
Alector Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Alector (ALEC) Projected to Post Quarterly Earnings on Wednesday - Defense World
Alector, Inc. (NASDAQ:ALEC) Stock Position Lifted by Vontobel Holding Ltd. - Defense World
Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call - GlobeNewswire
When Will Alector Report Q4 Earnings? Key Date for Biotech Investors - StockTitan
February 2025 US Penny Stocks With Promising Prospects - Simply Wall St
Alector (ALEC) to Release Quarterly Earnings on Tuesday - MarketBeat
25,000 Shares in Alector, Inc. (NASDAQ:ALEC) Acquired by Apollon Wealth Management LLC - Defense World
SG Americas Securities LLC Acquires 8,581 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus PT from Analysts - MarketBeat
Alector stock hits 52-week low at $1.59 amid market challenges - Investing.com Nigeria
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Average Target Price from Brokerages - Defense World
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update - br.ADVFN.com
Alector stock hits 52-week low at $1.59 amid market challenges By Investing.com - Investing.com South Africa
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update - br.ADVFN.com
Alector Inc (NASDAQ: ALEC) Has Succeeded To Excite In 2025, The Stock Is Down -7.41% Year-To-Date - Marketing Sentinel
ALEC Stock Sees Surge of Approximately 12.20% in Last Five Days - Knox Daily
Alector, Inc. (NASDAQ:ALEC) Short Interest Down 8.5% in January - MarketBeat
AbbVie terminates Alector collaboration agreement - MSN
Cantor Fitzgerald Comments on Alector FY2025 Earnings - Defense World
알렉터 (ALEC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
알렉터 주식 (ALEC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer |
Dec 02 '24 |
Sale |
2.52 |
52,172 |
131,442 |
2,507,074 |
| Kenkare-Mitra Sara | President and Head of R&D |
Dec 02 '24 |
Sale |
2.52 |
26,500 |
66,764 |
565,215 |
| Romano Gary | Chief Medical Officer |
Dec 02 '24 |
Sale |
2.52 |
14,892 |
37,519 |
349,283 |
1.77%
0.65%
자본화:
|
볼륨(24시간):